SCHEMBL5320071

SCHEMBL5320071

Cc1[nH]c(C(=O)CC2CCN(c3cc(C(=O)O)nc(Cl)n3)CC2)cc1Br

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 15/20 0.36
TTR P02766 9/20 0.36
DGAT1 O75907 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320276 0.90 LMNA (0.35) RBP4TTR
SCHEMBL3281210 0.83
SCHEMBL5319691 0.83 TOP2A (0.35) RBP4TTR
SCHEMBL3285352 0.75
SCHEMBL3288772 0.74
SCHEMBL3281480 0.73
SCHEMBL3281673 0.70
SCHEMBL3281451 0.69
SCHEMBL3281393 0.69
SCHEMBL594184 0.67 KMO (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856103-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS AstraZeneca AB (SE) 2007-11-21 EP claimed
WO-2006087544-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS ASTRAZENECA AB (SE) 2006-08-24 WO claimed
EP-1856103-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS AstraZeneca AB (SE) 2007-11-21 EP disclosed
WO-2006087544-A2 PYRROLE DERIVATIVES AS DNA GYRASE AND TOPOISOMERASE INHIBITORS ASTRAZENECA AB (SE) 2006-08-24 WO disclosed